These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 12172048)
1. Utility of thyroid transcription factor-1 and cytokeratin 20 in identifying the origin of metastatic carcinomas of cervical lymph nodes. Roh MS; Hong SH J Korean Med Sci; 2002 Aug; 17(4):512-7. PubMed ID: 12172048 [TBL] [Abstract][Full Text] [Related]
2. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens. Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468 [TBL] [Abstract][Full Text] [Related]
3. [Use of thyroid transcription factor-1, surfacfant protein-B, cytokeratin 7 and cytokeratin 20 in discrimination between primary and metastatic adenocarcinoma of lung]. Zou SM; Lin DM; Lü N; Liu XY; Wen P; Liu FS Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1350-2. PubMed ID: 12930693 [TBL] [Abstract][Full Text] [Related]
4. Thyroid transcription factor-1 and cytokeratins 7 and 20 in pulmonary and breast carcinoma. Harlamert HA; Mira J; Bejarano PA; Baughman RP; Miller MA; Whitsett JA; Yassin R Acta Cytol; 1998; 42(6):1382-8. PubMed ID: 9850647 [TBL] [Abstract][Full Text] [Related]
5. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors. Cai YC; Banner B; Glickman J; Odze RD Hum Pathol; 2001 Oct; 32(10):1087-93. PubMed ID: 11679943 [TBL] [Abstract][Full Text] [Related]
6. The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms. Chang YL; Lee YC; Liao WY; Wu CT Lung Cancer; 2004 May; 44(2):149-57. PubMed ID: 15084379 [TBL] [Abstract][Full Text] [Related]
7. Primary signet-ring cell carcinoma of lung: immunohistochemical study and comparison with non-pulmonary signet-ring cell carcinomas. Merchant SH; Amin MB; Tamboli P; Ro J; Ordóñez NG; Ayala AG; Czerniak BA; Ro JY Am J Surg Pathol; 2001 Dec; 25(12):1515-9. PubMed ID: 11717541 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical staining for thyroid transcription factor-1: a helpful aid in discerning primary site of tumor origin in patients with brain metastases. Srodon M; Westra WH Hum Pathol; 2002 Jun; 33(6):642-5. PubMed ID: 12152164 [TBL] [Abstract][Full Text] [Related]
9. Metastatic thoracic lymph node carcinoma of unknown origin on which we performed two kinds of immunohistochemical examinations. Yoshino N; Yamauchi S; Hino M; Ohaki Y; Koizumi K; Shimizu K Ann Thorac Cardiovasc Surg; 2006 Aug; 12(4):283-6. PubMed ID: 16977301 [TBL] [Abstract][Full Text] [Related]
10. Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B. Kaufmann O; Dietel M Histopathology; 2000 Jan; 36(1):8-16. PubMed ID: 10632746 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemistry of Cytokeratin 7, Cytokeratin 20 and Thyroid Transcription Factor-1 in Metastatic Carcinoma of Cervical Lymph Node Biopsy for Identification of Pulmonary Origin in Rajavithi Hospital. Kuakpaetoon T J Med Assoc Thai; 2017 Feb; 100 Suppl 1():S172-6. PubMed ID: 29927559 [TBL] [Abstract][Full Text] [Related]
12. Role of TTF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma. Su YC; Hsu YC; Chai CY Kaohsiung J Med Sci; 2006 Jan; 22(1):14-9. PubMed ID: 16570563 [TBL] [Abstract][Full Text] [Related]
13. [Surfactant protein and thyroid transcription factor 1 in pleuro-pulmonary neoplasia. Immunohistochemical study]. Dessy E; Falleni M; Del Curto B; Braidotti P; Pietra GG Pathologica; 2000 Dec; 92(6):496-502. PubMed ID: 11234300 [TBL] [Abstract][Full Text] [Related]
14. The value of immunohistochemical expression of TTF-1, CK7 and CK20 in the diagnosis of primary and secondary lung carcinomas. Al-Zahrani IH Saudi Med J; 2008 Jul; 29(7):957-61. PubMed ID: 18626520 [TBL] [Abstract][Full Text] [Related]
15. NKX3.1 as a marker of prostatic origin in metastatic tumors. Gurel B; Ali TZ; Montgomery EA; Begum S; Hicks J; Goggins M; Eberhart CG; Clark DP; Bieberich CJ; Epstein JI; De Marzo AM Am J Surg Pathol; 2010 Aug; 34(8):1097-105. PubMed ID: 20588175 [TBL] [Abstract][Full Text] [Related]
16. Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas. Ordóñez NG Am J Surg Pathol; 2000 Sep; 24(9):1217-23. PubMed ID: 10976695 [TBL] [Abstract][Full Text] [Related]